BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2007
View Archived Issues
Positive results for Regeneron's proof-of-concept study of rilonacept for gout / News in Context
Read More
Novel CXCR2 antagonist useful in models of acute and chronic inflammation
Read More
GenVec signs CRADA for malaria vaccine development
Read More
ProMetic Life Sciences expands PBI-1402 program to include cancer-related anemia
Read More
Positive results for Renovo's phase II trial of Juvista for treatment of wounds and scars
Read More
New antipsychotic, antidepressive and anxiolytic agents cited in patent literature
Read More
CRT, UCL and Novozymes to codevelop novel anticancer therapeutics
Read More
FDA opens Corcept's IND for Corlux for Cushing's syndrome allowing initiation of phase III study
Read More
Estrogen-dependent breast cancer growth in vivo suppressed by KW-2581
Read More
New compounds for treatment of HCV infection revealed
Read More
Recent patents impart new therapeutic agents for cancer
Read More
FDA Advisory Committees reaffirm current dosing practices for ESAs
Read More
Inhibitex licenses HIV integrase and hepatitis C polymerase inhibitors from UGARF
Read More
Phenomix begins phase IIb trial of PHX-1149 for type 2 diabetes
Read More
Phosphagenics to initiate phase II trials of TMP/Insulin for diabetes
Read More
BioSante and FDA reach agreement on LibiGel development requirements
Read More
Update on Aspreva and Roche's development of CellCept for lupus nephritis
Read More
Nventa begins phase I trial of HspE7 dosed with an adjuvant for CIN
Read More
Positive results for Chelsea's new formulation of CH-1504 for RA
Read More
Trubion reports preliminary analysis of phase IIb trial of TRU-015 for RA
Read More
New drug targets in neuropathic pain described
Read More
Minocycline shows neuroprotection in animal models of Alzheimer's disease
Read More
Pivotal phase III prophylactic HAE trial of Cinryze meets primary endpoint
Read More
FDA grants Metabasis' MB-07133 orphan drug designation for HCC
Read More
Novartis launches daptomycin for MSSA and MRSA bloodstream and heart infections
Read More